Serum uric acid and chronic kidney disease: The role of hypertension

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Sedaghat, Sanaz ^a   Hoorn, Ewout J ^a   Van Rooij, Frank J A ^a   Hofman, Albert ^a   Franco, Oscar H ^a   Witteman, Jacqueline C M ^a   Dehghan, Abbas ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; HYPERURICEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PROSPECTIVE STUDY; RELIABILITY; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; URIC ACID;

EID: 84893167142     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076827     Document Type: Article

References (47)

1. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266.
2. Smith DH, Gullion CM, Nichols G, Keith DS, Brown JB (2004) Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 15: 1300-1306. (Pubitemid 38526011)
3. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047. (Pubitemid 350074801)
4. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS (2009) Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 169: 342-350.
5. Sanchez-Lozada LG, Tapia E, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J (2005) Hemodynamics of hyperuricemia. Semin Nephrol 25: 19-24. (Pubitemid 40128144)
6. Yamada T, Fukatsu M, Suzuki S, Wada T, Joh T (2011) Elevated serum uric acid predicts chronic kidney disease. Am J Med Sci 342: 461-466.
7. Bellomo G, Venanzi S, Verdura C, Saronio P, Esposito A, et al. (2010) Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis 56: 264-272.
8. Ben-Dov IZ, Kark JD (2011) Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study. Nephrol Dial Transplant.
9. Cain L, Shankar A, Ducatman AM, Steenland K (2010) The relationship between serum uric acid and chronic kidney disease among Appalachian adults. Nephrol Dial Transplant 25: 3593-3599.
10. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, et al. (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44: 642-650. (Pubitemid 39237608)
11. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, et al. (2008) Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 19: 2407-2413.
12. Sonoda H, Takase H, Dohi Y, Kimura G (2011) Uric Acid Levels Predict Future Development of Chronic Kidney Disease. Am J Nephrol 33: 352-357.
13. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, et al. (2008) Uric acid and incident kidney disease in the community. J Am Soc Nephrol 19: 1204-1211.
14. Borges RL, Hirota AH, Quinto BM, Ribeiro AB, Zanella MT, et al. (2009) Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy. J Clin Hypertens (Greenwich) 11: 253-259.
15. Chen N, Wang W, Huang Y, Shen P, Pei D, et al. (2009) Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 24: 2117-2123.
16. Park JT, Kim DK, Chang TI, Kim HW, Chang JH, et al. (2009) Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant 24: 3520-3525.
17. Wang S, Shu Z, Tao Q, Yu C, Zhan S, et al. (2011) Uric Acid and Incident Chronic Kidney Disease in a Large Health Check-up Population in Taiwan. Nephrology (Carlton).
18. Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, et al. (2007) Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 50: 239-247. (Pubitemid 47095076)
19. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, et al. (2009) Uric acid and long-term outcomes in CKD. Am J Kidney Dis 53: 796-803.
20. See LC, Kuo CF, Chuang FH, Li HY, Chen YM, et al. (2009) Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. J Rheumatol 36: 1691-1698.
21. Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F, et al. (2008) Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol 43: 347-352.
22. Mene P, Punzo G (2008) Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens 26: 2085-2092.
23. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, et al. (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41: 1183-1190. (Pubitemid 36706063)
24. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7: 403-422.
25. Hofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, et al. (2011) The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 26: 657-686.
26. Trivedi RC, Rebar L, Berta E, Stong L (1978) New enzymatic method for serum uric acid at 500 nm. Clin Chem 24: 1908-1911. (Pubitemid 9049059)
27. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM (2006) Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 37: 1503-1507. (Pubitemid 44305733)
28. Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38: 1933-1953.
29. Drey N, Roderick P, Mullee M, Rogerson M (2003) A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 42: 677-684. (Pubitemid 37187367)
30. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
31. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
32. Ben-Dov IZ, Kark JD (2011) Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study. Nephrol Dial Transplant 26: 2558-2566.
33. Chien KL, Lin HJ, Lee BC, Hsu HC, Lee YT, et al. (2010) A prediction model for the risk of incident chronic kidney disease. Am J Med 123: 836-846 e832.
34. Kawashima M, Wada K, Ohta H, Terawaki H, Aizawa Y (2011) Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: A long-term retrospective cohort study. BMC Nephrol 12.
35. Mok Y, Lee SJ, Kim MS, Cui W, Moon YM, et al. (2011) Serum uric acid and chronic kidney disease: the Severance cohort study. Nephrol Dial Transplant.
36. Wang F, Zhang L, Zuo L, Liu L, Wang H (2011) Mortality and renal function decline among a community-based Chinese population with normal or mildly impaired renal function. Nephrol Dial Transplant 26: 2847-2852.
37. Yen CJ, Chiang CK, Ho LC, Hsu SHJ, Hung KY, et al. (2009) Hyperuricemia Associated With Rapid Renal Function Decline in Elderly Taiwanese Subjects. Journal of the Formosan Medical Association 108: 921-928.
38. Liu WC, Hung CC, Chen SC, Yeh SM, Lin MY, et al. (2012) Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 7: 541-548.
39. Siu YP, Leung KT, Tong MK, Kwan TH (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47: 51-59. (Pubitemid 41828266)
40. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, et al. (2010) Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5: 1388-1393.
41. Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, et al. (2005) Serum uric acid and target organ damage in primary hypertension. Hypertension 45: 991-996. (Pubitemid 40628949)
42. Grayson PC, Kim SY, LaValley M, Choi HK (2011) Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63: 102-110.
43. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, et al. (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41: 1287-1293. (Pubitemid 36706079)
44. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, et al. (2002) A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897. (Pubitemid 35386908)
45. Kahn AM (1988) Effect of diuretics on the renal handling of urate. Semin Nephrol 8: 305-314.
46. Bagnati M, Perugini C, Cau C, Bordone R, Albano E, et al. (1999) When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 340 (Pt 1): 143-152. (Pubitemid 29251101)
47. Bash LD, Coresh J, Kottgen A, Parekh RS, Fulop T, et al. (2009) Defining incident chronic kidney disease in the research setting: The ARIC Study. Am J Epidemiol 170: 414-424.